The purpose of this TriMark Publications report is to describe the sector trends within the point of care testing (POCT) diagnostic market. It examines those measurement devices and their reagents and supplies that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect cells and proteins for the purpose of diagnosis and monitoring of disease. This study includes all of the generally-accepted clinical analytical activities that are currently in use today. Additionally, an analysis of business and technology trends and developing areas of point of care and HPV testing is provided, along with a review of the market for point of care testing equipment and supplies in the clinical and research market segments, using screening reagents and instruments for analysis of individual components in blood, serum or plasma. This report defines U.S. and global market dollar sales volume and analyzes factors that influence the size and growth of market segments.

Table of Contents : 1. Overview 6
1.1 Statement of Report 6
1.2 Scope of the Report 8
1.3 Objectives 9
1.4 Methodology 9
1.5 Executive Summary 10

2. Overview of Diagnostic Point of Care Testing 12
2.1 Key Issues in the Point of Care Diagnostic Testing Sector 12
2.1.1 Current Market Trends and Drivers 12
2.1.2 Effectiveness of POCT 13
2.1.3 New Growth Areas for POCT 14
2.1.4 Advantages of POCT in a Clinical Setting 14
2.1.5 Pricing and Reimbursement Issues 14
2.1.6 Key Customer Segments 14
2.2 Global Point of Care Marketplace 14
2.3 Shifts from Central Lab Testing to POCT 16
2.4 Geographical Distribution 16
2.5 Emerging New Technologies 17
2.6 Challenges of POCT 18
2.7 Key Issues for POCT 18
2.7.1 Locations of POCT 18
2.7.2 Hospital Lab Rapid Tests 19
2.7.3 Doctor’s Office Laboratory 19
2.7.4 Non-Hospital POCT 19
2.7.5 Home Monitoring 19
2.7.6 Milestones in Technology Development 20
2.7.7 Drive for Decentralization from Lab to Patient 21
2.7.8 Expanded Reimbursement 21
2.7.9 Competitive Landscape for POCT 24
2.8 The Future of POCT 24

For more information, please visit :
http://www.aarkstore.com/reports/Point-of-Care-Diagnostic-Testing-Sector-Trends-1333.html
Or email us at [email protected] or call +919272852585

New York, NY – April 4, 2008 – BarterQuest.com, a Web site under development, announced that its parent company has initiated the process to establish international patents related to its proprietary trading and matching systems. BarterQuest.com will be a trading platform for the individual consumer that automatically matches the haves and wants of potential traders.

Dr. Paul Bocheck, the President of the Company, stated that “this will importantly extend the protection that is afforded by the U.S. domestic provisional patents filed in October 2006 and the three non-provisional patents filed in July 2007. BarterQuest will be a global site that supports trades in goods, services and real estate. The site will provide users with the unique ability to automatically navigate their trading alternatives to identify potential trades that respond to their specific preferences, whether such trades are between two parties or require multiple parties for their successful completion.”

BarterQuest.com is owned by JPM Global, Inc., a Delaware corporation. BarterQuest.com will be an interactive Web site for the cashless exchange of goods, services, and the use of real estate between individual consumers. Key word searches and the automatic matching of the haves and wants of users will facilitate two-party and multi-party trades. The Web site is undergoing alpha testing and will launch in 2008.

Except for historical information contained herein, this news release may contain forward looking statements that are subject to risks and uncertainties.

Contact:
Bianca Han, Executive Vice President
JPM Global, Inc.
231 West 29th Street
Suite 906
New York, NY 10001